4.5 Article

Mucoepidermoid Carcinoma A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis

Journal

AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Volume 43, Issue 7, Pages 885-897

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAS.0000000000001252

Keywords

salivary gland cancer; mucoepidermoid carcinoma; grade; MAML2; prognosis; recurrence

Funding

  1. NIDCR NIH HHS [K08 DE026500] Funding Source: Medline

Ask authors/readers for more resources

Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy, but categorization is complicated by variability in grading systems and uncertain prognostic significance of MAML2 rearrangement. The aims of this study were to determine the prognostic significance of MEC grading systems and MAML2 rearrangement status. Fifty-three carcinomas originally diagnosed as MEC (45 primary; 8 recurrent) of major and minor salivary glands were graded according to modified Healey, Brandwein, AFIP, and Katabi systems. Fluorescence in situ hybridization for MAML2 rearrangement was performed. Clinical features and outcomes were recorded. Twenty-five (47%) carcinomas scored the same in all grading systems. The most common histologic feature leading to a diagnosis of intermediate grade was isolated solid growth. Brandwein assigned the highest percentage of high grade (29%) and AFIP the highest percentage of low grade (80%). MAML2 was rearranged in 37/46 (80%) cases. Forty-three (81%) were morphologically compatible with MEC, and these were more likely to be low-intermediate grade and MAML2-rearranged. Of primary carcinomas, 6 (13%) recurred. Statistically significant univariate risk factors for recurrence included non-MEC morphology, stage T4, and high Brandwein grade. Margin status, MAML2 rearrangement, and isolated solid growth were not predictive of recurrence. A binary grading system (Brandwein high vs. low-plus-intermediate) could be considered to better reflect biological behavior in MEC. Our study confirms that MAML2 wildtype tumors more likely represent high grade non-MECs, and prior studies demonstrating worse prognosis in MAML2-nonrearranged MECs may be diluted by high-grade non-MECs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes

Corey C. Foster, Tanguy Y. Seiwert, Ellen MacCracken, Elizabeth A. Blair, Nishant Agrawal, James M. Melotek, Louis Portugal, Ryan J. Brisson, Zhen Gooi, Michael T. Spiotto, Everett E. Vokes, Daniel J. Haraf

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Pathology

Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features

James M. Dolezal, Anna Trzcinska, Chih-Yi Liao, Sara Kochanny, Elizabeth Blair, Nishant Agrawal, Xavier M. Keutgen, Peter Angelos, Nicole A. Cipriani, Alexander T. Pearson

Summary: Deep learning prediction of the BRAF-RAS gene expression spectrum can aid in distinguishing indolent NIFTP from PTCs, by detecting histologic features associated with the spectrum.

MODERN PATHOLOGY (2021)

Meeting Abstract Oncology

A phase I trial of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma

A. Rosenberg, N. Agrawal, Z. Gooi, E. A. Blair, A. T. Pearson, A. Juloori, L. Portugal, J. Chin, J. Cursio, M. Lingen, D. J. Haraf, E. E. Vokes

ANNALS OF ONCOLOGY (2021)

Meeting Abstract Oncology

Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.

Ari Rosenberg, Nishant Agrawal, Alexander T. Pearson, Tanguy Y. Seiwert, Zhen Gooi, Elizabeth A. Blair, Daniel Ginat, Adam Howard, Jeffrey Chin, Sara Kochanny, Evgeny Izumchenko, Aditya Juloori, Daniel J. Haraf, Everett E. Vokes

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

Ari J. Rosenberg, Evgeny Izumchenko, Alexander Pearson, Zhen Gooi, Elizabeth Blair, Theodore Karrison, Aditya Juloori, Daniel Ginat, Nicole Cipriani, Mark Lingen, Hillary Sloane, Daniel L. Edelstein, Kirsten Keyser, Johannes Fredebohm, Frank Holtrup, Frederick S. Jones, Daniel Haraf, Nishant Agrawal, Everett E. Vokes

Summary: Quantitative cfHPV-DNA can potentially serve as a reliable biomarker for assessing treatment response and guiding personalized treatment in HPV + OPC patients.

BMC CANCER (2022)

Article Oncology

Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience

Ari J. Rosenberg, Nishant Agrawal, Alexander Pearson, Zhen Gooi, Elizabeth Blair, John Cursio, Aditya Juloori, Daniel Ginat, Adam Howard, Jeffrey Chin, Sara Kochanny, Corey Foster, Nicole Cipriani, Mark Lingen, Evgeny Izumchenko, Tanguy Y. Seiwert, Daniel Haraf, Everett E. Vokes

Summary: The study on risk/response adaptive de-escalated treatment for HPV+ OPC showed excellent survival outcomes and reduced toxicity in patients with long-term follow-up.

ORAL ONCOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Multi-disciplinary management of patients with benign airway strictures: A review

Abhinav Agrawal, Brandon J. Baird, Maria Lucia L. Madariaga, Elizabeth A. Blair, Septimiu Murgu

Summary: Accurate diagnosis and appropriate treatment of airway strictures are crucial, and collaborative multidisciplinary teams can better manage patients, avoiding unnecessary surgeries and worsening disease course.

RESPIRATORY MEDICINE (2021)

Article Surgery

Large tracheoesophageal granular cell tumor: An atypical case presentation, location, and management

Ashley Diaz, Kenneth Yan, Nicole A. A. Cipriani, Elizabeth A. A. Blair

Summary: Granular cell tumors (GCTs) are rare tumors that often occur in the oral cavity. This case report presents a rare occurrence of a GCT near the trachea, where a 42-year-old man presented with a motor vehicle accident and was found to have a soft tissue mass in the retrotracheal area. Excision of the tumor confirmed it to be a GCT.

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2022)

Article Oncology

Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma

Ari J. Rosenberg, Nishant Agrawal, Alexander T. Pearson, Zhen Gooi, Elizabeth Blair, Louis Portugal, John F. Cursio, Aditya Juloori, Jeffrey Chin, Kathryn Rouse, Victoria M. Villaflor, Tanguy Y. Seiwert, Evgeny Izumchenko, Mark W. Lingen, Daniel J. Haraf, Everett E. Vokes

Summary: This study evaluated the treatment for recurrent head and neck squamous cell carcinoma using induction therapy with carboplatin and nab-paclitaxel, followed by concomitant FHX and different doses of nab-paclitaxel. The study found that the recommended dose for nab-paclitaxel in combination with FHX was 100 mg/m(2).

BRITISH JOURNAL OF CANCER (2022)

Review Otorhinolaryngology

Laryngeal and pharyngeal actinomycosis: a systematic review and report of 3 cases

Ashley Diaz, Thomas Cyberski, Armaan Singh, David Fenton, Nicole A. Cipriani, Jonathan J. Lusardi, Jacquelynne P. Corey, Elizabeth A. Blair

Summary: Actinomycosis is a rare infection that affects the larynx or pharynx. This study reviewed three cases and performed a literature review to better understand the surgical management, antibiotic therapy, risk factors, and incidence of recurrence or complications. The results showed an increased prevalence of pharyngolaryngeal actinomycosis in head and neck cancer patients. Extended antibiotic therapy showed favorable responses, and aggressive surgical management was generally not required.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Meeting Abstract Oncology

Nivolumab-based induction chemoimmunotherapy and PD-L1 expression in locoregionally advanced HPV-associated oropharyngeal squamous cell carcinoma.

Ari Rosenberg, Alexander T. Pearson, Nishant Agrawal, Aditya Juloori, Tanguy Y. Seiwert, Zhen Gooi, Elizabeth A. Blair, Evgeny Izumchenko, Jeffrey Chin, Daniel Ginat, Mark Lingen, Daniel J. Haraf, Everett E. Vokes

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Swallowing and quality-of-life outcomes of response adaptive de-escalated therapy following nivolumab-based induction for HPV plus oropharyngeal cancer.

Ari Rosenberg, Alexander T. Pearson, Aditya Juloori, John Cursio, Zhen Gooi, Elizabeth A. Blair, Tanguy Y. Seiwert, Jeffrey Chin, Ellen MacCracken, Evgeny Izumchenko, Nishant Agrawal, Daniel J. Haraf, Everett E. Vokes

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Omission of the Pathologic Node-Negative Neck From Postoperative Radiation Therapy for Oral Cavity Cancer

J. Hara, N. S. Ecanow, S. Uddin, A. J. Rosenberg, A. Pearson, D. Chan, E. A. Blair, N. Agrawal, N. Cipriani, M. Lingen, E. E. Vokes, Z. Gooi, D. J. Haraf, A. Juloori

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Organ Preservation with Definitive Chemoradiotherapy for T4 Laryngeal Squamous Cell Carcinoma

J. Hara, N. S. Ecanow, A. J. Rosenberg, A. Pearson, S. Kochanny, Z. Gooi, B. J. Baird, E. A. Blair, N. Agrawal, E. E. Vokes, D. J. Haraf, A. Juloori

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Oncology

Organ Preservation With Definitive Chemoradiotherapy for T4 Laryngeal Squamous Cell Carcinoma

J. Hara, A. J. Rosenberg, A. Pearson, Z. Gooi, B. J. Baird, E. A. Blair, N. Agrawal, E. E. Vokes, D. J. Haraf, A. Juloori

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

No Data Available